(Q37807885)

23 August 2017

The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV. (English)

1 reference

23 August 2017

0 references

arterial hypertension

0 references

portal hypertension

1 reference

inferred from title

hepatoportal sclerosis

1 reference

1 reference

Thomas D Schiano

1

1 reference

23 August 2017

Alison Uriel

series ordinal

2

1 reference

23 August 2017

Douglas T Dieterich

series ordinal

3

1 reference

23 August 2017

M Isabel Fiel

series ordinal

4

1 reference

23 August 2017

6 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

458

1 reference

23 August 2017

2

1 reference

23 August 2017

231-235

1 reference

https://scigraph.springernature.com/pub.10.1007/s00428-010-1004-7

23 August 2017

0 references

cites work

Hepatoportal sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Nodular regenerative hyperplasia: not all nodules are created equal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Idiopathic portal hypertension; a histopathological study of 26 Japanese cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Idiopathic portal hypertension and its pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Nonalcoholic fatty liver disease among HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Liver failure and the need for transplantation in three patients with hepatoportal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Hepatitis C virus in human immunodeficiency virus-infected individuals: an emerging comorbidity with significant implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1004-7

Variceal bleeding in an adolescent with HIV diagnosed with hepatoportal sclerosis and nodular regenerative hyperplasia

21 January 2018

1 reference

12 December 2020

Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy

1 reference

12 December 2020

Azathioprine and hepatic venocclusive disease in renal transplant patients

1 reference

12 December 2020

Liver transplantation for severe intrahepatic noncirrhotic portal hypertension

1 reference

12 December 2020

Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs

1 reference

12 December 2020

Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients

1 reference

12 December 2020

Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome

1 reference

12 December 2020

Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients

1 reference

12 December 2020

10.1007/S00428-010-1004-7

Identifiers

DOI

1 reference

23 August 2017

1 reference